NOVOS
<UNKNOWN> · 3 known investors
NOVOS is a longevity biotechnology company that develops science-validated supplement formulations and aging assessment tools designed to target the biological mechanisms of aging rather than disease symptoms. The company serves consumers seeking to extend healthspan through evidence-based products backed by clinical trials and mechanistic research.
Founders & leadership
CM
Chris MirabileFounder & CEO
Investors · 3
In the news
- NOVOS - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2023
- Fortnite training platform NOVOS raises $6m in fundingesportsinsider.com · 2022
- NOVOS raises $6 million Seed round to train gamers | Ctechcalcalistech.com · 2022
- NOVOS Closes $3.15M, Aims to Extend Healthy Human Lifespan With Science-Based Supplementsbusinesswire.com · 2021